Key facts
- This page summarizes Stephen Ray Mitchell's Form 4 filing for Vanda Pharmaceuticals Inc. (VNDA).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Jun 2021, 17:01.
Stephen Ray Mitchell - 15 Jun 2021 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)
- Reporting relationship
- Director
- Issuer ticker
- VNDA
- Reported as of
- 15 Jun 2021
- Net transaction value
- -$54,683
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2021, 17:01:10 UTC
- Prior SEC filing
- 14 Jun 2021
- Next SEC filing
- 13 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Ray Mitchell
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen Ray Mitchell filed Form 4 for Vanda Pharmaceuticals Inc. (VNDA) on 17 Jun 2021.
Change
- Previous filing in this sequence was filed on 14 Jun 2021.
- Current net transaction value: -$54,683.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VNDA
transaction
Common Stock
Options Exercise
- Transaction value
- $42,439
- Shares
- +4,015
- Change %
- +39%
- Price
- $10.57
- Shares after
- 14,215
- Date
- 15 Jun 2021
- Ownership
- Direct
VNDA
transaction
Common Stock
Sale
- Transaction value
- $97,122
- Shares
- -5,000
- Change %
- -35%
- Price
- $19.42
- Shares after
- 9,215
- Date
- 15 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VNDA
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,015
- Change %
- -40%
- Price
- $0.000000
- Shares after
- 5,985
- Date
- 15 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,015
- Exercise price
- $10.57
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
A portion of the shares was sold to satisfy the exercise price of the stock option and the tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.40 to $19.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Footnote F3
This option vested and became exercisable with respect to 100% of the option shares on June 11, 2021.